AVROBIO (AVRO)
(Delayed Data from NSDQ)
$1.52 USD
+0.06 (4.11%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $1.52 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
AVROBIO, Inc. [AVRO]
Reports for Purchase
Showing records 21 - 40 ( 114 total )
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
ASGCT 2022 Abstract Roundup For Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
AVRO Scores a Touchdown in Cystinosis at WORLDSymposium
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Fabry Takes the Backseat But Remaining Pipeline Still Cheap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Fabry Pivotal Lined Up Like Planes on the Runway
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Safety Data Should Hold The Fort Until WORLDSymposium
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department